Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2010; Correction, 41711 [E9-19779]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 158 / Tuesday, August 18, 2009 / Notices
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857,
Daniel.Gittleson@fda.hhs.gov, 301–796–
5156.
SUPPLEMENTARY INFORMATION: In the
Federal Register of May 21, 2009 (74 FR
23865), the agency announced that the
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0186. The
approval expires on July 31, 2012. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Dated: August 11, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. 09–19785 Filed 8–17–09; 8:45 am]
FR 17868), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0583. The
approval expires on July 31, 2012. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Dated: August 11, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–19784 Filed 8–17–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
BILLING CODE 4160–01–S
[Docket No. FDA–2009–N–0336]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Animal Drug User Fee Rates and
Payment Procedures for Fiscal Year
2010; Correction
AGENCY:
Food and Drug Administration
Food and Drug Administration,
HHS.
[Docket No. FDA–2008–N–0657]
ACTION:
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Recommendations for Early Food
Safety Evaluation of New NonPesticidal Proteins Produced by New
Plant Varieties Intended for Food Use
SUMMARY: The Food and Drug
Administration is correcting a notice
entitled that appeared in the Federal
Register of August 3, 2009 (74 FR
38429). The document announced the
Fiscal Year 2010 fee rates for the Animal
Drug User Fee Act. The document was
published with a typographical error.
This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
David Miller, Office of Financial
Management (HFA–100), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–3917.
SUPPLEMENTARY INFORMATION: In FR Doc.
E9–18459, appearing on page 38429 in
the Federal Register of Monday, August
3, 2009, the following correction is
made:
1. On page 38429, in the third
column, in the first sentence of the last
paragraph under Background,
‘‘$209,400’’ is corrected to read
‘‘$290,400’’.
AGENCY:
Food and Drug Administration,
HHS.
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Recommendations for Early Food
Safety Evaluation of New Non-Pesticidal
Proteins Produced by New Plant
Varieties Intended for Food Use’’ has
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857,
Daniel.Gittleson@fda.hhs.gov 301–796–
5156.
SUPPLEMENTARY INFORMATION: In the
Federal Register of April 17, 2009 (74
VerDate Nov<24>2008
16:30 Aug 17, 2009
Jkt 217001
Notice; correction.
41711
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel ZGM1–GDB–X–C1.
Date: September 8, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: John J. Laffan, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18J, Bethesda,
MD 20892, 301–594–2773.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: August 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19624 Filed 8–17–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0247]
Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–19779 Filed 8–17–09; 8:45 am]
Food and Drug Administration
Transparency Task Force; Reopening
of Comment Period
BILLING CODE 4160–01–S
HHS.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
AGENCY:
E:\FR\FM\18AUN1.SGM
Food and Drug Administration,
18AUN1
]]>Agencies
[Federal Register Volume 74, Number 158 (Tuesday, August 18, 2009)]
[Notices]
[Page 41711]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19779]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0336]
Animal Drug User Fee Rates and Payment Procedures for Fiscal Year
2010; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration is correcting a notice
entitled that appeared in the Federal Register of August 3, 2009 (74 FR
38429). The document announced the Fiscal Year 2010 fee rates for the
Animal Drug User Fee Act. The document was published with a
typographical error. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: David Miller, Office of Financial
Management (HFA-100), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-3917.
SUPPLEMENTARY INFORMATION: In FR Doc. E9-18459, appearing on page 38429
in the Federal Register of Monday, August 3, 2009, the following
correction is made:
1. On page 38429, in the third column, in the first sentence of the
last paragraph under Background, ``$209,400'' is corrected to read
``$290,400''.
Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-19779 Filed 8-17-09; 8:45 am]
BILLING CODE 4160-01-S
